AIP
CATX icon

Ameritas Investment Partners’s Perspective Therapeutics CATX Stock Holding History

Ameritas Investment Partners’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.8K Hold
5,476
– – ﹤0.01% 2534
2025
Q4 		$15.1K Hold
5,476
– – ﹤0.01% 2768
2025
Q3 		$18.8K Hold
5,476
– – ﹤0.01% 2688
2025
Q2 		$18.8K Hold
5,476
– – ﹤0.01% 2692
2025
Q1 		$11.7K Hold
5,476
– – ﹤0.01% 2774
2024
Q4 		$17.5K Hold
5,476
– – ﹤0.01% 2690
2024
Q3 		$73.1K Buy
5,476
+863
+19% +$11.5K ﹤0.01% 1970
2024
Q2 		$46K Buy
+4,613
New +$66.7K ﹤0.01% 2184

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameritas Investment Partners's CATX Position: Q1 2026 in Review

Ameritas Investment Partners held its Perspective Therapeutics (CATX) position steady in Q1 2026 at 5,476 shares worth $22.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2534.

Ameritas Investment Partners first reported a position in CATX in Q2 2024 and has held it in 8 quarters since. The position peaked at $73.1K in Q3 2024. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • Ameritas Investment Partners held 5,476 shares of Perspective Therapeutics worth $22.8K as of Q1 2026.
  • Ameritas Investment Partners left its Perspective Therapeutics share count unchanged in Q1 2026.
  • Perspective Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2534 holding.
  • Ameritas Investment Partners first reported a position in Perspective Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Ameritas Investment Partners's Perspective Therapeutics position peaked at $73.1K in Q3 2024.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.